Sign in

CIK 0001737287

  • Non-accelerated filer
  • Smaller reporting company

Allogene Therapeutics, Inc.

Sign in to watch
Ticker
ALLO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
823562771
Phone
+1 650-457-2700
Business address
210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$48,698
in 1 filing

Net −$48,698. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Parker Geoffrey M. −$49K CHIEF FINANCIAL OFFICER sold 3% of stake
Date Insider Transaction Shares Price Value Owned after
2026-02-02 Belldegrun Arie Director Grant or award · Stock Option (Right to buy) +929,913 929,913
2026-02-02 Belldegrun Arie Director Grant or award · Restricted Stock Unit +263,033 263,033
2025-01-24 Belldegrun Arie Director Grant or award +369,957 2,236,816
2025-01-24 Belldegrun Arie Director Grant or award · Stock Option (Right to buy) +1,307,927 1,307,927
2024-05-16 Belldegrun Arie Director Grant or award +344,828 $2.90 $1.0M 539,867
2024-05-16 Belldegrun Arie Director Purchase +1,724,137 $2.90 $5.0M 1,724,137
2024-01-25 Belldegrun Arie Director Grant or award +211,973 1,866,859
2024-01-25 Belldegrun Arie Director Grant or award · Stock Option (Right to buy) +749,398 749,398
2023-03-22 Belldegrun Arie Director Grant or award +1,282,976 1,654,886
2023-03-22 Belldegrun Arie Director Grant or award · Stock Option (Right to Buy) +994,800 994,800
2022-03-23 Belldegrun Arie Director Grant or award · Stock Option (Right to Buy) +1,458,333 1,458,333
2022-03-14 Belldegrun Arie Director Other disposition −4,710,120 0
2022-03-14 Belldegrun Arie Director Other acquisition +4,710,120 4,710,120
2022-03-14 Belldegrun Arie Director Other disposition −4,710,121 0
2022-03-14 Belldegrun Arie Director Other acquisition +4,710,121 4,710,121
2022-01-12 Belldegrun Arie Director Purchase +155,039 $12.60 $2.0M 195,039
2021-05-24 Belldegrun Arie Director Exercise or conversion +379,066 $18.22 $6.9M 583,034
2021-05-24 Belldegrun Arie Director Exercise or conversion · Stock Option (Right to Buy) −379,066 0
2021-03-26 Belldegrun Arie Director Grant or award +53,635 203,968
2021-03-26 Belldegrun Arie Director Grant or award · Stock Option (Right to Buy) +199,223 199,223

Page 1 of 2 · 37 trades